The passing of world leading legislation on new psychoactive substances takes New Zealand a big step closer to healthy drug law, the New Zealand Drug Foundation said today.
“The Psychoactive Substances Act is a world first at getting ahead of the ‘legal highs’ industry and taking control of the problems these substances cause,” New Zealand Drug Foundation Executive Director Ross Bell said.
The law, which passed its final reading in Parliament today, sets up a regulatory framework where manufacturers of products like synthetic cannabis will have to prove they are ‘low risk’ before the can be sold. It also imposes restrictions on who can make and sell the substances as well as measures to reduce availability.
“This is a cutting edge and pragmatic approach to new psychoactive substances which will reduce the harm they cause in our communities,” Mr Bell said.
“It is fantastic that the Government has listened to community concerns, acted on the evidence and built consensus on the best way to handle this complicated area of policy.”
Mr Bell said that the regulation of new psychoactive substances was the first step in the right direction for healthy drug law.
“New Zealand now needs to implement broader health-focussed changes to our outdated drug laws.”
Kali Mercier sets out what we know in 2020, and outlines how the need to collect accurate information has never been greater.
Indigenous Canadians have been dissatisfied with the way cannabis legalisation has failed to work for them.
A glimpse of what happened at Auckland Town Hall at the Unify Rally on Monday 16 September. Photographer Katrina Elton was on hand to captu...
Although medicinal cannabis was made legal in New Zealand, the medical profession has been slow to widely adopt the new option. Russell Brow...
Back to top